Clinical Trial Update: Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of tildrakizumab 100 mg in adults with moderate to severe chronic plaque psoriasis and the impact on quality of lif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED